Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Feb 7, 2022

Ted Karkus is the CEO of ProPhase Labs, which is in the battle to provide rapid results from PCR tests for COVID-19. While expecting a winter spike, Ted has been surprised at the record-breaking demand the latest Omicron variant has created. ProPhase Labs has recently acquired Nebula Genomics to provide whole genome...


Feb 7, 2022

Ted Karkus is the CEO of ProPhase Labs, which is in the battle to provide rapid results from PCR tests for COVID-19. While expecting a winter spike, Ted has been surprised at the record-breaking demand the latest Omicron variant has created. ProPhase Labs has recently acquired Nebula Genomics to provide whole genome...


Jan 26, 2022

Steven Goh is the CEO of Achiko which is developing a COVID-19 test based around using a DNA aptamer, a small strand of oligonucleotides, as an alternative to using an antigen. When saliva is placed in a colloidal solution and read by a spectrophotometer, smart software can then classify if the person is likely to be...


Jan 26, 2022

Steven Goh is the CEO of Achiko which is developing a COVID-19 test based around using a DNA aptamer, a small strand of oligonucleotides, as an alternative to using an antigen. When saliva is placed in a colloidal solution and read by a spectrophotometer, smart software can then classify if the person is likely to be...


Jan 13, 2022

Alain Moussy is the Co-Founder and CEO of AB Science a clinical-stage company designing and developing novel drugs to address diseases with high unmet medical needs. Masitinib, their drug in development is being investigated in neurological diseases such as amyotrophic lateral sclerosis, Alzheimer's, and multiple...